Close Menu

Considering that there are now 4,000 to 5,000 tests for heritable conditions, the question of how good is any test if it doesn't lead to actionable results is on the mind of a lot of people in the consumer genetic testing industry. Scripps' Eric Topol is conducting an experiment to see if taking a test (in this case, they're using Navigenics) will spur people to actually improve their lifestyles. Most experts still urge caution. If you're not taking the test under genetic counseling supervision, you might as well skip it, says one.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Lancet has made changes to its peer-review process in response to its recent retraction of a COVID-19-related paper, Science reports.

The New York Times reports that a series of emails show how Department of Health and Human Services officials sought to silence the Centers for Disease Control and Prevention.

A new initiative aims to move Australia's genome sequencing labs onto one system, the Sydney Morning Herald reports.

In PLOS this week: recessive mutation tied to early-onset dilated cardiomyopathy, epigenetic analysis of lung adenocarcinoma, and more.